Avian Influenza Vaccines Market to Influence the Value of USD 196.25 Million by 2029
Global Avian Influenza Vaccines Market report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and their strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions which are applicable for the businesses with which they can take better steps to improve their strategies to sell goods and services. Market research presents actionable market insights which help create sustainable and money-spinning business strategies. An absolute way to forecast what future holds is to comprehend the trend today. Thus, with Global Avian Influenza Vaccines Market business report, more important aspects of the HEALTHCARE industry can be focused.
Avian influenza, commonly known as bird flu, is a viral virus that transmits from birds to other animals including people. The virus was discovered for the first time in China. In the following year, during an outbreak in Hong Kong, the Asian H5N1 strain was discovered, and it has since spread throughout Europe, Asia, North and South America, Africa, and the Middle East. Based on its molecular structure, avian influenza can be classified as highly pathogenic or low pathogenic. The virus is classified as H5N1, H7N3, H7N7, H7N9, and H9N2 depending on the strains. Furthermore, the virus of type A of subtype H5N1 is currently being studied as the most virulent avian influenza virus.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-avian-influenza-vaccines-market&Shri
Data Bridge Market Research analyses that the avian influenza vaccines market was valued at USD 124.53 million in 2021 and is expected to reach USD 196.25 million by 2029, registering a CAGR of 5.85% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
| REPORT METRIC | DETAILS |
| Forecast Period | 2022 to 2029 |
| Base Year | 2021 |
| Historic Years | 2020 (Customizable to 2019 – 2014) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
| Segments Covered | Vaccine Type (Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines), Application (Chicken, Duck and Goose, Others), Strain (H5 Strain, H7 Strain, H9 Strain) |
Avian influenza is an infectious disease caused by the type-A virus found in birds. Aquatic birds are the virus’s most common carrier. The avian influenza type A virus is characterized as either neuraminidase (NA) or hemagglutinin (HA) based on protein remains on its surface (HA). It is classified as either highly pathogenic or low pathogenic based on molecular features. If the virus gets into the eyes, nose, or mouth, it can cause serious illness. For infection prevention and treatment, the antiviral drugs oseltamivir and zanamivir are included in the Avian Influenza Vaccines. Ducks, chickens, geese, and other birds are all known to consume it.
Drivers
- Surging frequency of illness in developing countries
The rise in frequency of illness in developing countries will act as a major driver that will result in the expansion of the growth rate of the market. Infections are becoming more common in developing countries, which could lead to an increase in poultry mortality. At the same time, the increased demand for chicken for human consumption demands additional research to develop effective disease-prevention vaccines. Using gene editing methods, chickens can be rendered resistant to avian flu. In addition, particular legislation allow for the eradication of hen bird flu.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of avian influenza vaccines market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising initiatives by public and private organizations to spread awareness about avian influenza and rising healthcare expenditure will expand the avian influenza vaccines market. Additionally, increasing demand for poultry for consumption and rise in the number of outbreaks will result in the expansion of avian influenza vaccines market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market’s growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the avian influenza vaccines market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
- Rise in the number of strategic collaborations
The increasing number of strategic collaborations will boost new as well as profitable market opportunities in the coming years. Strategic cooperation between commercial and government entities to develop healthcare solutions, as well as combined efforts in the digitalization of medical aid facilities, could help the industry flourish.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the avian influenza vaccines market growth during the forecast period.
Some of the major players operating in the avian influenza vaccines market are:
- Sanofi (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mallinckrodt (US)
- Elanco (US)
- Boehringer Ingelheim International GmbH. (Germany)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (US)
- Merck & Co., Inc. (US)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Virbac (France)
- Vetoquinol (France)
- Zoetis (US)
- Ceva (France)
- Bimeda, Inc. (US)
- Phibro Animal Health Corporation (US)
- HIPRA (Spain)
- Medion (Germany)
- YEBIO BIOENGINEERING CO., LTD OF QINGDAO (China)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-avian-influenza-vaccines-market?Shri
Avian Influenza Vaccines Market Scope
Vaccine Type
- Inactivated Vaccines
- Live Recombinant Vaccines
- Combination Vaccines
Application
- Chicken
- Duck and Goose
- Others
Strain
- H5 Strain
- H7 Strain
- H9 Strain
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Fundamental Aim of this Market Report
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Key highlights of this Market report:
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-avian-influenza-vaccines-market&Shri
Critical Insights Related to the adalimumab biosimilar Included in the Report:
-
- Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
